Kolibri

Kolibri plays music to cells to unlock the cell culture revolution.
‍
Advanced therapies and cultivated meat, whilst extremely promising, are facing the same bottleneck: large-scale cell culture and engineering.

Current bioproduction techniques are indeed limited both in terms of scalability and efficiency, leading to high production costs and limited yield.

Rise of genetherapy

The success of biological drugs in the treatment of major chronic diseases has catapulted acceptance of innovative therapies, including gene therapies.
But large scale manufacturing of their key component, viral vector, is significantly expensive and face major scalability and quality bottlenecks

We are rethinking the way we grow mammalian cells using acoustic waves

We create the next-generation of bioreactors specifically designed to handle mammalian cells.

Leveraging acoustic waves, our technology allows for increased yield while reducing production costs.

We are starting with AAV gene therapy manufacturing and will soon transfer our platform to manufacturing other cell-based therapies.

Efficient
‍

Competitive cost
‍

Quality
‍

Negligible costly transfection reagents and media consumption

Increased yield thanks to high cell density and purification efficiency

More therapeutic vectors in viral vector doses

Treat

Personalized calibrations are made to calculate an optimal hydration range

Monitor

Users are notified before their hydration levels move above or below that range

Share

Keepinig users In The Blue

Amélie Quilichini

Co-Founder, CEO

With an engineering background, Amélie has 7 years of experience managing deeptech projects. She successfully launched a B2B hardware startup for one of her clients.

Co-Founder, CTO

Gabriel is one of the few people on earth mastering the physics behind acoustic cell manipulation techniques. He holds a PhD in acoustophoresis and over 7 years of experience developing acoustic devices applied to biology on lab and industrial scales and has an excellent capacity to manage a technical team.

Florian Dittmann

Physics Development Engineer

Engineer and with training in chemical and mechanical engineering, after completing a PhD optimizing processes and energy systems striving for efficient energy conversion, Florian now exploits his skills in computational fluid mechanics, thermodynamics and hardware development at Kolibri.

Mechanical Engineer

Graduate from Georgia Institute of Technology and Arts et Métiers ParisTech - École Nationale Supérieure d'Arts et Métiers Marin Virey brings a unique set of skills in mechanical engineer, conception and prototyping.

Mathilde Maëstrali

Senior Cell Culture Scientist

Pharmacy doctor well versed in mammalian cell bioproduction, Mathilde brings her expertise in making cell grow in innovative processes to the Kolibri team.

VP Product Development

Phil brings 40 years of experience in leading industrial product development (especially with medical devices, single use components, etc.) from R&D to market access,.

Noémie Cavanna

Bioproduction Senior Technician

Graduated in cellular biology and biology analysis, Noémie has a strong academic background and extensive practical experience in various biological techniques. Her expertise includes cell culture at various scales, characterization, and bioprocessing.

Electronics Engineer

University of Liverpool Electrical Engineering and Electronics PhD, she worked with semiconductor nanoparticles with a specific insight into the development of photo- and bio-sensing. Her experience is also in dielectrophoresis nanoparticle solutions manipulation, along with nanowires biofunctionalization methods for saliva COVID-19 detection.

Kolibri is always looking for exceptional and driven talents. Please contact us with a cover letter and resume if you think you may be a good fit.

Join the bioproduction revolution right now

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.